Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study page now shows a 403 Forbidden error page, replacing the usual study record content and navigation.SummaryDifference19%

- Check18 days agoChange DetectedRevision tag on the Study Details page updated from v3.6.6 to v3.7.0. This change indicates a metadata maintenance update rather than a modification to the study content.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision history now shows new August 2026 entries and Revision: v3.6.6. The older July 2026 entries and Revision: v3.6.5 are no longer listed.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded the line 2023 ( U.S. NIH Grant/Contract ) in the study's funding information. This identifies the NIH as a funder for the year 2023, providing transparency about support for the trial.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows Revision: v3.6.5, replacing v3.6.4. This indicates a backend or CMS update rather than a change to study details or visible content.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now states that recruitment is closed with the note 'No longer looking for participants', and associated recruitment prompts and contact details have been removed. This reflects that the study is not actively enrolling at this time.SummaryDifference2%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.